10 research outputs found
MHC Class I Chain-Related Gene A Polymorphisms and Linkage Disequilibrium with HLA-B and HLA-C Alleles in Ocular Toxoplasmosis.
This study investigated whether polymorphisms of the MICA (major histocompatibility complex class I chain-related gene A) gene are associated with eye lesions due to Toxoplasma gondii infection in a group of immunocompetent patients from southeastern Brazil. The study enrolled 297 patients with serological diagnosis of toxoplasmosis. Participants were classified into two distinct groups after conducting fundoscopic exams according to the presence (n = 148) or absence (n = 149) of ocular scars/lesions due to toxoplasmosis. The group of patients with scars/lesions was further subdivided into two groups according to the type of the ocular manifestation observed: primary (n = 120) or recurrent (n = 28). Genotyping of the MICA and HLA alleles was performed by the polymerase chain reaction-sequence specific oligonucleotide technique (PCR-SSO; One Lambda®) and the MICA-129 polymorphism (rs1051792) was identified by nested polymerase chain reaction (PCR-RFLP). Significant associations involving MICA polymorphisms were not found. Although the MICA*002~HLA-B*35 haplotype was associated with increased risk of developing ocular toxoplasmosis (P-value = 0.04; OR = 2.20; 95% CI = 1.05-4.60), and the MICA*008~HLA-C*07 haplotype was associated with protection against the development of manifestations of ocular toxoplasmosis (P-value = 0.009; OR: 0.44; 95% CI: 0.22-0.76), these associations were not statistically significant after adjusting for multiple comparisons. MICA polymorphisms do not appear to influence the development of ocular lesions in patients diagnosed with toxoplasmosis in this study population
Genetic Susceptibility to Cardiac and Digestive Clinical Forms of Chronic Chagas Disease: Involvement of the CCR5 59029 A/G Polymorphism.
The clinical manifestations of chronic Chagas disease include the cardiac form of the disease and the digestive form. Not all the factors that act in the variable clinical course of this disease are known. This study investigated whether the CCR5Δ32 (rs333) and CCR5 59029 A/G (promoter region--rs1799987) polymorphisms of the CCR5 gene are associated with different clinical forms of chronic Chagas disease and with the severity of left ventricular systolic dysfunction in patients with chronic Chagas heart disease (CCHD). The antibodies anti-T. cruzi were identified by ELISA. PCR and PCR-RFLP were used to identify the CCR5Δ32 and CCR5 59029 A/G polymorphisms. The chi-square test was used to compare variables between groups. There was a higher frequency of the AA genotype in patients with CCHD compared with patients with the digestive form of the disease and the control group. The results also showed a high frequency of the AG genotype in patients with the digestive form of the disease compared to the other groups. The results of this study show that the CCR5Δ32 polymorphism does not seem to influence the different clinical manifestations of Chagas disease but there is involvement of the CCR5 59029 A/G polymorphism in susceptibility to the different forms of chronic Chagas disease. Besides, these polymorphisms do not influence left ventricular systolic dysfunction in patients with CCHD
<i>CCR5</i> 59029 A/G polymorphism analysis using the recessive inheritance model.
<p><sup>a</sup> DF: Degrees of freedom</p><p><sup>b</sup> Calculated by χ<sup>2</sup>.</p><p><i>CCR5</i> 59029 A/G polymorphism analysis using the recessive inheritance model.</p
Frequency of genotypes and alleles of the <i>CCR5</i>Δ32 polymorphism in patients with chronic Chagas disease and control subjects.
<p><sup>a</sup> DF: Degrees of freedom</p><p><sup>b</sup> Calculated by χ<sup>2</sup>.</p><p>Frequency of genotypes and alleles of the <i>CCR5</i>Δ32 polymorphism in patients with chronic Chagas disease and control subjects.</p
<i>CCR5</i> 59029 A/G polymorphism analysis using the dominant inheritance model.
<p><sup>a</sup> DF: Degrees of freedom</p><p><sup>b</sup> Calculated by χ<sup>2</sup>.</p><p><i>CCR5</i> 59029 A/G polymorphism analysis using the dominant inheritance model.</p
Frequency of genotypes and alleles of the <i>CCR5</i> 59029 A/G polymorphism in patients with Chagas disease and control subjects
<p><sup>a</sup> DF: Degrees of freedom</p><p><sup>b</sup> Calculated by χ<sup>2</sup>.</p><p>Frequency of genotypes and alleles of the <i>CCR5</i> 59029 A/G polymorphism in patients with Chagas disease and control subjects</p
Frequency of genotypes and alleles of the <i>CCR5</i> 59029 A/G polymorphism in patients with chronic Chagas heart disease with normal left ventricular systolic function, mild to moderate, and severe left ventricular systolic dysfunction.
<p>LVSD: Left ventricular systolic dysfunction</p><p><sup>a</sup> DF: Degrees of freedom</p><p><sup>b</sup> Calculated by χ<sup>2</sup>.</p><p>Frequency of genotypes and alleles of the <i>CCR5</i> 59029 A/G polymorphism in patients with chronic Chagas heart disease with normal left ventricular systolic function, mild to moderate, and severe left ventricular systolic dysfunction.</p